Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7619
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeller, Sebastian-
dc.contributor.authorTibubos, Ana Nanette-
dc.contributor.authorHoff, Thilo A.-
dc.contributor.authorWerner, Antonia M.-
dc.contributor.authorReichel, Jennifer L.-
dc.contributor.authorMülder, Lina M.-
dc.contributor.authorSchäfer, Markus-
dc.contributor.authorPfirrmann, Daniel-
dc.contributor.authorStark, Birgit-
dc.contributor.authorRigotti, Thomas-
dc.contributor.authorSimon, Perikles-
dc.contributor.authorBeutel, Manfred E.-
dc.contributor.authorLetzel, Stephan-
dc.contributor.authorDietz, Pavel-
dc.date.accessioned2023-03-06T10:24:46Z-
dc.date.available2023-03-06T10:24:46Z-
dc.date.issued2022-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7633-
dc.description.abstractAiming to develop and implement intervention strategies targeting pharmacological neuroenhancement (PN) among university students more specifically, we (1) assessed the prevalence of PN among German university students, (2) identified potential sociodemographic and study-related risk groups, and (3) investigated sociodemographic, psychological, study-related psychosocial, general psychosocial and health behavior related factors predicting the 12-month prevalence of PN. Therefore, a cross-sectional online survey was administered to students of the University of Mainz, Germany. A binary logistic regression with stepwise inclusion of the five variable groups was performed to predict PN. A total number of 4351 students out of 31,213 registered students (13.9%) participated in the survey, of which N = 3984 answered the question concerning PN. Of these, 10.4% had used one substance for PN at least once in the past 12 months. The regression analysis revealed 13 variables that were significantly related to the 12-month prevalence of PN. Specifically, the group of health behavior related variables showed the strongest relationship with PN. Therefore, an approach to the prevention of PN should be multifactorial so that it addresses social conditions, as well as education on substance use and healthy behaviors in terms of non-pharmacological strategies as alternatives of PN.en_GB
dc.description.sponsorshipGefördert durch die Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 491381577de
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titlePotential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germanyen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7619-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleScientific reportsde
jgu.journal.volume12de
jgu.pages.alternative937de
jgu.publisher.year2022-
jgu.publisher.nameMacmillan Publishers Limited, part of Springer Naturede
jgu.publisher.placeLondonde
jgu.publisher.issn2045-2322de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1038/s41598-022-04891-yde
jgu.organisation.rorhttps://ror.org/023b0x485-
jgu.subject.dfgLebenswissenschaftende
Appears in collections:DFG-491381577-G

Files in This Item:
  File Description SizeFormat
Thumbnail
potential_risk_groups_and_psy-20220823111215154.pdf1.12 MBAdobe PDFView/Open